- Home
- SERA vs HYFT Comparison
SERA vs HYFT Comparison
Compare SERA & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SERA | HYFT |
|---|---|---|
| Founded | 2008 | 1983 |
| Country | United States | United States |
| Employees | N/A | 102 |
| Industry | Precision Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.2M | 71.9M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | SERA | HYFT |
|---|---|---|
| Price | $2.29 | $1.68 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 62.4K | ★ 500.2K |
| Earning Date | 05-06-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.32 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $81,000.00 | N/A |
| Revenue This Year | $554.81 | N/A |
| Revenue Next Year | $517.27 | $29.18 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 5.19 | N/A |
| 52 Week Low | $1.37 | $0.99 |
| 52 Week High | $4.09 | $3.00 |
Technical Indicators
Market Signals| Indicator | SERA | HYFT |
|---|---|---|
| Relative Strength Index (RSI) | 61.45 | 56.50 |
| Support Level | $1.67 | $1.50 |
| Resistance Level | $2.40 | $2.06 |
| Average True Range (ATR) | 0.21 | 0.20 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 84.63 | 60.13 |
Price Performance
Historical ComparisonAbout SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
About HYFT MindWalk Holdings Corp.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.